Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-10-080471
Filing Date
2010-04-09
Accepted
2010-04-09 15:50:37
Documents
12
Period of Report
2010-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11703
2 ANNUAL REPORT dex991.htm EX-99.1 867255
3 GRAPHIC g91036g19w84.jpg GRAPHIC 7254
4 GRAPHIC g91036g29t10.jpg GRAPHIC 28105
5 GRAPHIC g91036g31c41.jpg GRAPHIC 19785
6 GRAPHIC g91036g42o49.jpg GRAPHIC 4470
7 GRAPHIC g91036g70l30.jpg GRAPHIC 110287
8 GRAPHIC g91036g75a99.jpg GRAPHIC 7270
9 GRAPHIC g91036g78e73.jpg GRAPHIC 8378
10 GRAPHIC g91036g78e78.jpg GRAPHIC 4291
11 GRAPHIC g91036g91g08.jpg GRAPHIC 7332
12 GRAPHIC g91036g92h46.jpg GRAPHIC 6539
  Complete submission text file 0001193125-10-080471.txt   1162528
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 10742597
SIC: 2834 Pharmaceutical Preparations